Expand KYTX Menu
KYTX MENU

KYTX Latest Press Releases

-- August 11, 2026 --

Kyverna Therapeutics Reports Pipeline Progress and Second Quarter 2026 Financial Results Globe Newswire 4:02 PM

-- July 27, 2026 --

Kyverna Therapeutics and ElevateBio Enter into Commercial Manufacturing and Supply Agreement for Miv-cel Globe Newswire 8:00 AM

-- June 22, 2026 --

Kyverna Therapeutics Appoints Ritesh Srivastava as Chief Legal and Compliance Officer, Adding Leadership Strength to Support Commercial-Stage Transition Globe Newswire 8:00 AM

-- June 3, 2026 --

Kyverna Therapeutics Highlights Updated Miv-cel Data at EULAR Demonstrating Substantial Reduction in Disease Activity in ACPA-Positive, Treatment Refractory Rheumatoid Arthritis Globe Newswire 8:00 AM

-- May 18, 2026 --

Kyverna Therapeutics Names Greg Martini as Chief Financial Officer Globe Newswire 8:00 AM

-- May 14, 2026 --

Kyverna Therapeutics to Present at Upcoming Investor Conferences Globe Newswire 8:00 AM

-- May 12, 2026 --

Kyverna Therapeutics Announces Initiation of Rolling SPS BLA Submission and Reports First Quarter 2026 Financial Results Globe Newswire 4:02 PM

-- May 4, 2026 --

Kyverna Therapeutics Appoints Nadia Dac, Seasoned Commercial Leader in Neurology and Rare Disease, as Chief Commercial Officer Globe Newswire 8:00 AM

-- April 21, 2026 --

Kyverna Presents Registrational Trial Primary Analysis for Miv-cel in Stiff Person Syndrome Demonstrating Statistically Significant, Durable Clinical Benefit Across All Endpoints in an Oral, Late-Breaker Session at AAN Annual Meeting Globe Newswire 6:45 PM

-- April 20, 2026 --

Kyverna Presents Longer-Term Phase 2 Data for Miv-cel in Generalized Myasthenia Gravis at AAN, Demonstrating Deep, Durable Responses through 52 Weeks Globe Newswire 8:00 AM

-- April 9, 2026 --

Kyverna Therapeutics to Host Conference Call on New Data Across Neuroimmunology Franchise at AAN 2026 Globe Newswire 8:00 AM

-- March 26, 2026 --

Kyverna Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results Globe Newswire 4:02 PM
Market Data Delayed 15 Minutes